Literature DB >> 25027666

Clinically isolated syndromes and the relationship to multiple sclerosis.

Wallace J Brownlee1, David H Miller2.   

Abstract

The most common presentation of multiple sclerosis (MS) is with a clinically isolated syndrome (CIS) affecting the optic nerves, brainstem or spinal cord. Two thirds of patients with CIS will have further episodes of neurological dysfunction and convert to relapsing-remitting MS, while the remaining patients have a monophasic illness, at least clinically. Abnormalities on a baseline MRI scan predict the subsequent development of MS in patients with CIS. In the long term, about 80% of patients with an abnormal MRI convert to MS compared with 20% with a normal MRI. For patients who develop MS the long term prognosis is varied. After 20 years, almost half will have developed secondary progressive MS, while around one third have a benign disease course with little physical disability. Disease-modifying treatments delay conversion to MS in selected CIS patients with abnormal MRI but an effect on long term disability has not been demonstrated. In this review we discuss recent advances in the diagnosis, management and prognostication of patients with CIS.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clinically isolated syndrome; Demyelinating disease; Multiple sclerosis; Optic neuritis

Mesh:

Substances:

Year:  2014        PMID: 25027666     DOI: 10.1016/j.jocn.2014.02.026

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  20 in total

Review 1.  The tension between early diagnosis and misdiagnosis of multiple sclerosis.

Authors:  Andrew J Solomon; John R Corboy
Journal:  Nat Rev Neurol       Date:  2017-08-11       Impact factor: 42.937

Review 2.  The Relevance of Neuroimaging Findings to Physical Disability in Multiple Sclerosis.

Authors:  Rahşan Göçmen
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

Review 3.  [Diagnosis of multiple sclerosis: revision of the McDonald criteria 2017].

Authors:  O Aktas; M P Wattjes; M Stangel; H-P Hartung
Journal:  Nervenarzt       Date:  2018-12       Impact factor: 1.214

4.  Accurate Machine Learning Model to Diagnose Chronic Autoimmune Diseases Utilizing Information From B Cells and Monocytes.

Authors:  Yuanchen Ma; Jieying Chen; Tao Wang; Liting Zhang; Xinhao Xu; Yuxuan Qiu; Andy Peng Xiang; Weijun Huang
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786

Review 5.  Consensus opinion of US neurologists on practice patterns in RIS, CIS, and RRMS: Evolution of treatment practices.

Authors:  Carlo Tornatore; J Theodore Phillips; Omar Khan; Aaron E Miller; Mark Hughes
Journal:  Neurol Clin Pract       Date:  2016-08

6.  Sympathetic cardiovascular and sudomotor functions are frequently affected in early multiple sclerosis.

Authors:  Mario Habek; Luka Crnošija; Mila Lovrić; Anamari Junaković; Magdalena Krbot Skorić; Ivan Adamec
Journal:  Clin Auton Res       Date:  2016-07-22       Impact factor: 4.435

Review 7.  Radiologically Isolated Syndrome: A Review for Neuroradiologists.

Authors:  M Hosseiny; S D Newsome; D M Yousem
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-06       Impact factor: 3.825

Review 8.  Paediatric clinically isolated syndromes: report of seven cases, differential diagnosis and literature review.

Authors:  Chiara Trabatti; Thomas Foiadelli; Maria Valentina Spartà; Chiara Gagliardone; Berardo Rinaldi; Maria Delmonte; Alessandro Lozza; Salvatore Savasta
Journal:  Childs Nerv Syst       Date:  2015-11-19       Impact factor: 1.475

9.  Clinically Isolated Syndrome According to McDonald 2010: Intrathecal IgG Synthesis Still Predictive for Conversion to Multiple Sclerosis.

Authors:  Philipp Schwenkenbecher; Anastasia Sarikidi; Lena Bönig; Ulrich Wurster; Paul Bronzlik; Kurt-Wolfram Sühs; Refik Pul; Martin Stangel; Thomas Skripuletz
Journal:  Int J Mol Sci       Date:  2017-09-27       Impact factor: 5.923

10.  Onset Symptom Clusters in Multiple Sclerosis: Characteristics, Comorbidities, and Risk Factors.

Authors:  Vladeta Ajdacic-Gross; Nina Steinemann; Gábor Horváth; Stephanie Rodgers; Marco Kaufmann; Yanhua Xu; Christian P Kamm; Jürg Kesselring; Zina-Mary Manjaly; Chiara Zecca; Pasquale Calabrese; Milo A Puhan; Viktor von Wyl
Journal:  Front Neurol       Date:  2021-07-06       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.